MedShadow, July 23, 2024: We agree with Medshadow that it is outrageous that the FDA is warning companies about fraudulent tests that mean their medications may not be safe or effective but are not warning patients who are buying these medications.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
Revolving door: You are free to influence us “behind the scenes,” FDA tells staff leaving for industry jobs
BMJ, July 1, 2024: BMJ investigation reveals how revolving door and FDA Ethics office allow former FDA staff to lobby for industry and Dr. Diana Zuckerman explains how this creates conflicts of interest that undermine FDA decision-making.
Read More »Advisory Committee Consumer Reps Often Fail To Represent Consumer Interests, Groups Tell US FDA
Pink Sheet, June 13, 2024: NCHR quoted from FDA listening session on optimizing the advisory committee process.
Read More »Readers respond to mothers in treatment for opioid use disorder, pandemic models, and more
STAT, June 8, 2024: Our Letter to the Editor at STAT News disagreed with the first Opinion commentary urging more use of antipsychotics for dementia patients. We explain that these drugs too often kill older patients or serve as chemical straight jackets,
Read More »Representatives ponder balance of regulation, innovation in health care
Medical Economics, May 9, 2024: House Small Business Committee hearing focused on when government regulations undermine medical innovation and services but also agreed on the need to ensure safe and effective medical products.
Read More »